|
RRP8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.39799999999235E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.564920E-03 |
| Normal-vs-Stage2 |
4.542200E-03 |
| Normal-vs-Stage3 |
8.357500E-04 |
| Normal-vs-Stage4 |
8.36459999999928E-05 |
| Stage1-vs-Stage2 |
3.453600E-01 |
| Stage1-vs-Stage3 |
3.657400E-01 |
| Stage1-vs-Stage4 |
1.456170E-01 |
| Stage2-vs-Stage3 |
8.204400E-01 |
| Stage2-vs-Stage4 |
8.999600E-01 |
| Stage3-vs-Stage4 |
6.596000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.90339999999978E-05 |
| Normal-vs-AfricanAmerican |
3.802000E-03 |
| Normal-vs-Asian |
3.655900E-02 |
| Caucasian-vs-AfricanAmerican |
7.759400E-01 |
| Caucasian-vs-Asian |
3.255900E-02 |
| AfricanAmerican-vs-Asian |
3.038000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.86339999999863E-05 |
| Normal-vs-Female |
1.970730E-04 |
| Male-vs-Female |
9.711200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.462300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.203160E-04 |
| Normal-vs-Age(61-80Yrs) |
6.398200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.030250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.100800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.011200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.176000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.241600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.222400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.973400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.771310E-04 |
| Normal-vs-Grade 2 |
7.858900E-03 |
| Normal-vs-Grade 3 |
3.999500E-04 |
| Normal-vs-Grade 4 |
2.17849999994968E-06 |
| Grade 1-vs-Grade 2 |
1.575570E-02 |
| Grade 1-vs-Grade 3 |
4.752100E-02 |
| Grade 1-vs-Grade 4 |
7.005400E-01 |
| Grade 2-vs-Grade 3 |
3.494600E-01 |
| Grade 2-vs-Grade 4 |
6.702100E-03 |
| Grade 3-vs-Grade 4 |
3.265500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.762200E-02 |
| Normal-vs-ccB subtype |
1.76161999999591E-05 |
| ccA subtype-vs-ccB subtype |
1.921520E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.840700E-04 |
| Normal-vs-N1 |
1.413880E-02 |
| N0-vs-N1 |
4.929600E-02 |
|
|
